341 related articles for article (PubMed ID: 20006878)
1. An update of the Gleason grading system.
Epstein JI
J Urol; 2010 Feb; 183(2):433-40. PubMed ID: 20006878
[TBL] [Abstract][Full Text] [Related]
2. Gleason score 3+3=6 prostatic adenocarcinoma is not benign and the current debate is unhelpful to clinicians and patients.
Samaratunga H; Egevad L; Yaxley J; Perry-Keene J; Le Fevre I; Kench J; Matsika A; Bostwick D; Iczkowski K; Delahunt B
Pathology; 2024 Feb; 56(1):33-38. PubMed ID: 38071161
[TBL] [Abstract][Full Text] [Related]
3. Prognosis of Gleason Score 9-10 Prostatic Adenocarcinoma in Needle Biopsies: A Nationwide Population-based Study.
Egevad L; Micoli C; Samaratunga H; Delahunt B; Garmo H; Stattin P; Eklund M
Eur Urol Oncol; 2024 Apr; 7(2):213-221. PubMed ID: 37978024
[TBL] [Abstract][Full Text] [Related]
4. A distinct repertoire of cancer-associated fibroblasts is enriched in cribriform prostate cancer.
Hesterberg AB; Rios BL; Wolf EM; Tubbs C; Wong HY; Schaffer KR; Lotan TL; Giannico GA; Gordetsky JB; Hurley PJ
J Pathol Clin Res; 2021 May; 7(3):271-286. PubMed ID: 33600062
[TBL] [Abstract][Full Text] [Related]
5. Prognosis of Gleason score 8 prostatic adenocarcinoma in needle biopsies: a nationwide population-based study.
Egevad L; Micoli C; Delahunt B; Samaratunga H; Orrason AW; Garmo H; Stattin P; Eklund M
Virchows Arch; 2024 Apr; ():. PubMed ID: 38683251
[TBL] [Abstract][Full Text] [Related]
6. Critical evaluation of artificial intelligence as a digital twin of pathologists for prostate cancer pathology.
Eminaga O; Abbas M; Kunder C; Tolkach Y; Han R; Brooks JD; Nolley R; Semjonow A; Boegemann M; West R; Long J; Fan RE; Bettendorf O
Sci Rep; 2024 Mar; 14(1):5284. PubMed ID: 38438436
[TBL] [Abstract][Full Text] [Related]
7. Temporal changes in the pathologic assessment of prostate cancer.
Lucia MS; Bokhoven Av
J Natl Cancer Inst Monogr; 2012 Dec; 2012(45):157-61. PubMed ID: 23271767
[TBL] [Abstract][Full Text] [Related]
8. Visual Assessment of 2-Dimensional Levels Within 3-Dimensional Pathology Data Sets of Prostate Needle Biopsies Reveals Substantial Spatial Heterogeneity.
Koyuncu C; Janowczyk A; Farre X; Pathak T; Mirtti T; Fernandez PL; Pons L; Reder NP; Serafin R; Chow SSL; Viswanathan VS; Glaser AK; True LD; Liu JTC; Madabhushi A
Lab Invest; 2023 Dec; 103(12):100265. PubMed ID: 37858679
[TBL] [Abstract][Full Text] [Related]
9. Intraductal Carcinoma of the Prostate: A Guide for the Practicing Pathologist.
Varma M
Adv Anat Pathol; 2021 Jul; 28(4):276-287. PubMed ID: 33990497
[TBL] [Abstract][Full Text] [Related]
10. The evolving Gleason grading system.
Chen N; Zhou Q
Chin J Cancer Res; 2016 Feb; 28(1):58-64. PubMed ID: 27041927
[TBL] [Abstract][Full Text] [Related]
11. Morphologic patterns observed in prostate biopsy cases with discrepant grade group and molecular risk classification.
Greenland NY; Cooperberg MR; Carroll PR; Cowan JE; Simko JP; Stohr BA; Chan E
Prostate; 2024 May; ():. PubMed ID: 38734990
[TBL] [Abstract][Full Text] [Related]
12. Distinct Adverse Clinical Outcomes of Small and Large Cribriform Patterns on Gleason 7 Prostate Cancer: A Preliminary Study.
Kazan O; Kadioglu N; Ivelik Hİ; Sevim M; Alkis O; Coser S; Kartal IG; Aras B
Urol Res Pract; 2023 Sep; 49(5):324-328. PubMed ID: 37877881
[TBL] [Abstract][Full Text] [Related]
13. Contemporary grading of prostate cancer: 2017 update for pathologists and clinicians.
Gasparrini S; Cimadamore A; Scarpelli M; Massari F; Doria A; Mazzucchelli R; Cheng L; Lopez-Beltran A; Montironi R
Asian J Androl; 2017 Aug; 21(1):19-23. PubMed ID: 28782737
[TBL] [Abstract][Full Text] [Related]
14. ProGleason-GAN: Conditional progressive growing GAN for prostatic cancer Gleason grade patch synthesis.
Golfe A; Del Amor R; Colomer A; Sales MA; Terradez L; Naranjo V
Comput Methods Programs Biomed; 2023 Oct; 240():107695. PubMed ID: 37393742
[TBL] [Abstract][Full Text] [Related]
15. An international multi-institutional validation study of the algorithm for prostate cancer detection and Gleason grading.
Tolkach Y; Ovtcharov V; Pryalukhin A; Eich ML; Gaisa NT; Braun M; Radzhabov A; Quaas A; Hammerer P; Dellmann A; Hulla W; Haffner MC; Reis H; Fahoum I; Samarska I; Borbat A; Pham H; Heidenreich A; Klein S; Netto G; Caie P; Buettner R
NPJ Precis Oncol; 2023 Aug; 7(1):77. PubMed ID: 37582946
[TBL] [Abstract][Full Text] [Related]
16. Contemporary Diagnostic Reporting for Prostatic Adenocarcinoma: Morphologic Aspects, Molecular Correlates, and Management Perspectives.
Muthusamy S; Smith SC
Adv Anat Pathol; 2024 May; 31(3):188-201. PubMed ID: 38525660
[TBL] [Abstract][Full Text] [Related]
17. Topline/Final Diagnostic Inclusion of Relevant Histologic Findings in Surgical Pathology Reporting of Carcinoma in Prostate Biopsies.
Mullane P; Williamson SR; ; Sangoi AR
Int J Surg Pathol; 2024 Mar; ():10668969241231972. PubMed ID: 38504649
[TBL] [Abstract][Full Text] [Related]
18. Automatic Prostate Gleason Grading Using Pyramid Semantic Parsing Network in Digital Histopathology.
Qiu Y; Hu Y; Kong P; Xie H; Zhang X; Cao J; Wang T; Lei B
Front Oncol; 2022; 12():772403. PubMed ID: 35463378
[TBL] [Abstract][Full Text] [Related]
19. ISUP Consensus Definition of Cribriform Pattern Prostate Cancer.
van der Kwast TH; van Leenders GJ; Berney DM; Delahunt B; Evans AJ; Iczkowski KA; McKenney JK; Ro JY; Samaratunga H; Srigley JR; Tsuzuki T; Varma M; Wheeler TM; Egevad L
Am J Surg Pathol; 2021 Aug; 45(8):1118-1126. PubMed ID: 33999555
[TBL] [Abstract][Full Text] [Related]
20. A systematic comparison of deep learning methods for Gleason grading and scoring.
Dominguez-Morales JP; Duran-Lopez L; Marini N; Vicente-Diaz S; Linares-Barranco A; Atzori M; Müller H
Med Image Anal; 2024 Jul; 95():103191. PubMed ID: 38728903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]